Find Gabapentin Enacarbil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

24 RELATED EXCIPIENT COMPANIES

44EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 478296-72-9, Horizant, Regnite, Xp-13512, Solzira, Xp13512
Molecular Formula
C16H27NO6
Molecular Weight
329.39  g/mol
InChI Key
TZDUHAJSIBHXDL-UHFFFAOYSA-N
FDA UNII
75OCL1SPBQ

Gabapentin Enacarbil
Gabapentin enacarbil is marketed under the name Horizant. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
1 2D Structure

Gabapentin Enacarbil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid
2.1.2 InChI
InChI=1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)
2.1.3 InChI Key
TZDUHAJSIBHXDL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O
2.2 Other Identifiers
2.2.1 UNII
75OCL1SPBQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic Acid

2. Xp 10569

3. Xp 11084

4. Xp 11239

5. Xp 12464

6. Xp 13512

7. Xp-10569

8. Xp-11084

9. Xp-11239

10. Xp-12464

11. Xp-13512

12. Xp10569

13. Xp11084

14. Xp11239

15. Xp12464

16. Xp13512

2.3.2 Depositor-Supplied Synonyms

1. 478296-72-9

2. Horizant

3. Regnite

4. Xp-13512

5. Solzira

6. Xp13512

7. Asp8825

8. Xp 13512

9. Gsk1838262

10. Asp-8825

11. 75ocl1spbq

12. Gsk-1838262

13. Chebi:68840

14. 2-(1-((((1-(isobutyryloxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic Acid

15. 2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic Acid

16. {1-[({[1-(isobutyryloxy)ethoxy]carbonyl}amino)methyl]cyclohexyl}acetic Acid

17. (1-(((((1rs)-1-((2-methylpropanoyl)oxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic Acid

18. (1-{[({(1rs)-1-[isobutyryloxy]ethoxy}carbonyl) Amino]methyl}cyclohexyl)acetic Acid

19. Cyclohexaneacetic Acid, 1-((((1-(2-methyl-1-oxopropoxy)ethoxy)carbonyl)amino)methyl)-

20. Gabapentin Encarbil

21. Unii-75ocl1spbq

22. Gsk 1838262

23. Gabapentin Enacarbil [usan:inn]

24. Gabapentin-encarbil

25. Horizant (tn)

26. Asp 8825

27. Gabapentine Enacarbil

28. Gabapentina Enacarbilo

29. Gabapentinum Enacarbilum

30. Schembl25455

31. Gtpl7560

32. Chembl1628502

33. Gabapentin Encarbil [mi]

34. Dtxsid30870359

35. Gabapentin Enacarbil [inn]

36. Gabapentin Enacarbil [jan]

37. Gabapentin Enacarbil [usan]

38. Bcp12845

39. Gabapentin Enacarbil [vandf]

40. Gabapentin Enacarbil [mart.]

41. Mfcd09954124

42. Xp-053

43. Gabapentin Enacarbil [who-dd]

44. Akos025290727

45. Gabapentin Enacarbil (jan/usan/inn)

46. Cs-1698

47. Db08872

48. Pb32822

49. 1-[[[[1-(2-methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]cyclohexaneacetic Acid

50. Ncgc00532500-01

51. Ac-27644

52. As-35192

53. Gabapentin Enacarbil [orange Book]

54. Hy-16216

55. Db-070861

56. Ft-0753836

57. A20372

58. D09539

59. 296g729

60. Q5515257

61. {[(1-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

62. {[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

63. 1-{[(alpha-isobutanovloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

64. 1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

65. 1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexaneacetic Acid

66. 2-[1-[[[1-[(2-methylpropanoyl)oxy]ethoxy]carbonylamino]methyl]cyclohexyl]acetic Acid

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 329.39 g/mol
Molecular Formula C16H27NO6
XLogP33.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass329.18383758 g/mol
Monoisotopic Mass329.18383758 g/mol
Topological Polar Surface Area102 Ų
Heavy Atom Count23
Formal Charge0
Complexity428
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameHorizant
Drug LabelHORIZANT (gabapentin enacarbil) is a prodrug of gabapentin. Gabapentin enacarbil is described as (1-{[({(1RS)-1-[(2-Methylpropanoyl)oxy]ethoxy}carbonyl)amino]methyl} cyclohexyl) acetic acid. It has a molecular formula of C16H27NO6 and a molecular wei...
Active IngredientGabapentin enacarbil
Dosage FormTablet, extended release
RouteOral
Strength600mg; 300mg
Market StatusPrescription
CompanyXenoport

2 of 2  
Drug NameHorizant
Drug LabelHORIZANT (gabapentin enacarbil) is a prodrug of gabapentin. Gabapentin enacarbil is described as (1-{[({(1RS)-1-[(2-Methylpropanoyl)oxy]ethoxy}carbonyl)amino]methyl} cyclohexyl) acetic acid. It has a molecular formula of C16H27NO6 and a molecular wei...
Active IngredientGabapentin enacarbil
Dosage FormTablet, extended release
RouteOral
Strength600mg; 300mg
Market StatusPrescription
CompanyXenoport

4.2 Drug Indication

For the treatment of adult Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Since gabapentin enacarbil is a prodrug of gabapentin, it's physiological effects are the same as gabapentin. Concerning PHN, gabapentin prevents allodynia and hyperalgesia.


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]; Anti-epileptic Agent [EPC]
5.3 Absorption, Distribution and Excretion

Absorption

Gabapentin enacarbil is absorbed in the intestines by active transport through the proton-linked monocarboxylate transporter, MCT-1.


Route of Elimination

Gabapentin enacarbil is eliminated primarily in the urine (94%) and to a lesser extent in the feces (5%).


Volume of Distribution

The volume of distribution is 76L.


Clearance

Renal clearance of gabapentin is 5 to 7 L/hr.


5.4 Metabolism/Metabolites

Gabapentin enacarbil does not interact with any of the major cytochrome P450 enzymes.


5.5 Biological Half-Life

The elimination half-life of gabapentin is 5.1 to 6.0 hours.


5.6 Mechanism of Action

Although the exact mechanism of action of gabapentin in RLS and PHN is unknown, it is presumed to involve the descending noradrenergic system, resulting in the activation of spinal alpha2-adrenergic receptors.


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300MG

USFDA APPLICATION NUMBER - 22399

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 600M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 600MG

USFDA APPLICATION NUMBER - 22399

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Lubricants & Glidants

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Taste Masking

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty